Aethlon Medical to Present at 12th International Conference on Dialysis

Jan 19, 2010, 11:13 ET from Aethlon Medical, Inc.

SAN DIEGO, Jan. 19 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis, will give a clinical presentation of the Aethlon Hemopurifier® at the 12th International Conference on Dialysis on January 22nd.  The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care.  The conference will be held at the Marriott New Orleans in New Orleans, Louisiana.  Additional information, including the speaker agenda, can be accessed online at: http://www.renalresearch.com.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

Contacts:

RedChip Companies, Inc.

Jon Cunningham

1-800-733-2447, Ext. 107

Jon@redchip.com

Jim Joyce

Chairman, CEO

858.459.7800 x301

jj@aethlonmedical.com

Jim Frakes

Senior VP Finance

858.459.7800 x300

jfrakes@aethlonmedical.com

SOURCE Aethlon Medical, Inc.



RELATED LINKS

http://www.aethlonmedical.com


http://www.renalresearch.com